Pre-treatment 2D Scout Verification Tolerances and Dosimetry Effects on OARs for the Cylinder High Dose Rate Brachytherapy Treatment of Vaginal Cuff Cancer

Purposes: to statistically find out the achievable and practical pre-treatment verification tolerances for HDR (high dose rate) cylinder treatment using scout AP (anterior and posterior) /LAT (lateral) images and the corresponding organs at risk dosimetry effects. Materials and Methods: Five previously treated vaginal cuff cancer patients were randomly selected. All of the patients had prescription of 5 mm above the cylinder surface with 500 cGy per fraction for 5 fractions. The treatment plans were developed using the Oncentra treatment planning system with graphical local optimization method. Two scouts (AP/LAT) were taken during CT (computed tomography) scan day and on the treatment day of each fraction. The dummy source was placed in the cylinder and the tip of the dummy source to the top of the pubic bone vertical distance on the AP scout was recorded. The cylinder diameter was also measured. The LAT dummy source angle relative to the horizontal line was also recorded. The treatment for each fraction was then reconstructed using AP/LAT scout images. The source position was registered back to the planning CT. A dummy cumulative plan was then created with a prescription of 2500 cGy for 1 fraction. Results: The AP shifts were ranging from -5 mm to 10 mm and the LAT shifts were ranging from -13° to 9°. The percentage median dose difference can be ranging up 0.3%-14% for the rectum and -17.8%-8.0% for the bladder. Based on the statistics results, we propose the pre-treatment simulation tolerances: trying to maintain the cylinder in AP direction shift under 5 mm, a warning zone is 5 mm-10 mm. For the lateral angle, the tolerance is trying to maintain the angle difference under 5 degree with 5-10 degree as warning zone. Conclusion: We have done pre-treatment simulation quality assurance study using AP/LAT scout images. The tolerance for this pre-treatment simulation was proposed. The relative dosimetry effects for the rectum and bladder were reported. PACS number: 87.55. Gh, 87.55. km, 87.55. Qr, 87.55. tm Central Shi et al. (2013) Email: [email protected] JSM Clin Oncol Res 1(1): 1001 (2013) 2/3 mm above the cylinder surface with 500 cGy per fraction for 5 fractions. The patients’ general information is listed in table 1. The patients were scanned using GE lightspeed CT (computed tomography) simulator with a slice thickness 2.5 mm. The cylinder, rectum, bladder were contoured by a physician. The isodose 100% was normalized to the catheter points which were created with active catheter dwell positions with a distance of half of the cylinder diameter size plus 5 mm. The isodose 100% distribution was further optimization using Oncentra treatment planning system (Nucletron, an Elekta company, Atlanta, GA, version 4.1) graphical local optimization method. The 100% isodose line was dragged to conform to the catheter points and follow the cylinder tip curvature. Two scouts (anterior-posteriorAP and lateral-LAT direction) were taken during CT scan day. The dummy source was placed in the cylinder and the tip of the dummy source to the top of the pubic bone vertical distance on the AP scout was measured as baseline. The cylinder diameter was also measured for 2nd check of the applicator. The LAT dummy source angle relative to the horizontal line was also measured as baseline. A typical AP and LAT scout images were shown as Figure 1. For each fraction treatment, two similar scout images were taken to verify the insert angle, distance, and application diameter. The patient was then transferred using stretcher to the treatment room once the simulation was done and the physician approved for treatment. In order to reconstruct the treatment for each fraction, the scout images including the baseline scouts were imported into Oncentra treatment planning system and the source were reconstructed. The reconstruction origin was the right femur bone center. The dwell position time and relative weight were the same as the plan. The reconstructed source coordinates were recorded. The planning source coordinates and the baseline source coordinates were then co-registered using threedimensional rigid registration method as shown in equation (1). ' X RX T = + (1), Where X is the reconstructed baseline source coordinates and X’ is the planning CT coordinates. The rotation matrix R and transformation matrix T were then determined by using Singular Value Decomposition (SVD) method. Once the rotation and transformation were known, other fractions source coordinates were then able to be transferred into the planning CT coordinates. A full set treatment sources reconstruction in CT coordinates were illustrated in Figure 2. A dummy plan was then created with a prescription of 2500 cGy for 1 fraction. Each of the five reconstructed catheters was given the same dwell time as the plan. The cumulative dose was then computed. Since the reconstructed catheter 100% isodose may invade into either the bladder or rectum, only the median dose for the bladder and rectum were considered for relatively dosimetry effect. Patient ID Age Staging Diameter (mm) Active length (mm) P1 67 T1 NX MX 35 40 P2 37 T1a N0 M0 30 40 P3 69 T1a N0 M0 35 45 P4 92 T2 NX MX 35 40 P5 64 T1a N0 M0 30 40 table 1: General patient information.